Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Trial details
- Registry ID
- NCT05995405
- Drugs studied
- GTX-104, Nimotop 30 MG Oral Capsule
TrialRedline tracks 1 clinical trial sponsored by Grace Therapeutics Inc.: 1 Phase 3.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAHNCT05995405 | GTX-104, Nimotop 30 MG Oral Capsule | Active not recruiting | 2024-12Estimated |
Names as written in the registry records.